Back
CRISPR Therapeutics AG Stock Price Chart
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
11
CRSP
CRISPR Therapeutics AG
Last Price:
$40.51
Seasonality Move:
0.72%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40 | Buy |
| 20-day SMA: | 40.38 | Buy |
| 50-day SMA: | 45.65 | Sell |
| 200-day SMA: | 51.21 | Sell |
| 8-day EMA: | 40.05 | Buy |
| 20-day EMA: | 41.26 | Sell |
| 50-day EMA: | 44.04 | Sell |
| 200-day EMA: | 50.41 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.61 | Sell |
| Relative Strength Index (14 RSI): | 44.09 | Sell |
| Chaikin Money Flow: | -1163251 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.11 - 43.57) | Sell |
| Bollinger Bands (100): | (42.72 - 50.16) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 40.53 while CRSP 8-day simple moving average is 40.00, which is a Buy signal.
-
The stock price of CRSP is 40.53 while CRISPR Therapeutics AG 20-day SMA is 40.38, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 45.65 while CRSP share price is 40.53, making it a Sell technically.
-
CRSP stock price is 40.53 and CRISPR Therapeutics AG 200-day simple moving average is 51.21, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
11
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $40.53. The Score for CRSP is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.5B
Price in USD:
40.53
Share Volume:
1.4M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
36.52
Sell
11
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 40.53 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 40.53 while CRSP 8-day exponential moving average is 40.05, which is a Buy signal.
-
The stock price of CRSP is 40.53 while CRISPR Therapeutics AG 20-day EMA is 41.26, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day exponential moving average is 44.04 while CRSP share price is 40.53, making it a Sell technically.
-
CRSP stock price is 40.53 and CRISPR Therapeutics AG 200-day simple moving average is 50.41, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $2.12 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is -1.61, suggesting CRISPR Therapeutics AG is a Sell
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 44.09, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (39.11 - 43.57), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (42.72 - 50.16), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.